These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2047978)

  • 1. Risk assessment of biological hazards in the biotechnology industry.
    Liberman DF; Israeli E; Fink R
    Occup Med; 1991; 6(2):285-99. PubMed ID: 2047978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Legal and regulatory considerations in environmental biotechnology applications.
    McGarity TO
    Recomb DNA Tech Bull; 1985 Mar; 8(1):1-6. PubMed ID: 3858922
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety aspects in biotechnology. Classifications and safety precautions for handling of biological agents.
    Frommer W; Krämer P
    Arzneimittelforschung; 1990 Jul; 40(7):837-42. PubMed ID: 2222560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applicability of chemical risk assessment methodologies to risk assessment for genetically engineered microorganisms.
    Dean-Ross D
    Recomb DNA Tech Bull; 1986 Mar; 9(1):16-28. PubMed ID: 3458267
    [No Abstract]   [Full Text] [Related]  

  • 5. The promise and perils of synthetic biology.
    Tucker JB; Zilinskas RA
    New Atlantis; 2006; 12():25-45. PubMed ID: 16832953
    [No Abstract]   [Full Text] [Related]  

  • 6. Containment considerations for the biotechnology industry.
    Liberman DF; Fink R
    Occup Med; 1991; 6(2):271-83. PubMed ID: 2047977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congressional hearing on the adequacy of current statutes and scientific knowledge for the regulation of biotechnology.
    Milewski E
    Recomb DNA Tech Bull; 1985 Mar; 8(1):7-16. PubMed ID: 3858924
    [No Abstract]   [Full Text] [Related]  

  • 8. Physical hazards from start-up to manufacturing.
    Liffers M
    Occup Med; 1991; 6(2):183-91. PubMed ID: 2047972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testimony of the American Society for Microbiology before the House Subcommittee on Investigations and Oversight, House Subcommittee on Natural Resources, Agriculture Research and Environment, and the House Subcommittee on Science, Research and Technology of the House Committee on Science and Technology. Hearing on "The coordinated framework for the regulation of biotechnology", July 23, 1986.
    Riley M
    Recomb DNA Tech Bull; 1986 Sep; 9(3):151-61. PubMed ID: 3466239
    [No Abstract]   [Full Text] [Related]  

  • 10. Biosecurity. Synthetic biologists debate policing themselves.
    Service RF
    Science; 2006 May; 312(5777):1116. PubMed ID: 16728599
    [No Abstract]   [Full Text] [Related]  

  • 11. Grafting for transgene containment.
    Lev-Yadun S; Sederoff R
    Nat Biotechnol; 2001 Dec; 19(12):1104. PubMed ID: 11731772
    [No Abstract]   [Full Text] [Related]  

  • 12. [Problems of safety in biotechnology. Products of genetic engineering and regulation of work with them].
    Vorob'ev AA; Chugasova VA; Korovkin VI
    Mol Gen Mikrobiol Virusol; 1987 Sep; (9):3-10. PubMed ID: 3323899
    [No Abstract]   [Full Text] [Related]  

  • 13. The science and intricacy of environmental safety evaluations.
    Käppeli O; Auberson L
    Trends Biotechnol; 1997 Sep; 15(9):342-9. PubMed ID: 9293032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotechnology guidelines.
    Nature; 1986 Sep 11-17; 323(6084):104. PubMed ID: 3462508
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of products from biotechnology.
    Sharples FE
    Science; 1987 Mar; 235(4794):1329-32. PubMed ID: 3823888
    [No Abstract]   [Full Text] [Related]  

  • 16. DNA: have the corporations already grabbed control of new life forms?
    Rifkin J
    Mother Jones; 1977; 2(2):23-39. PubMed ID: 11649384
    [No Abstract]   [Full Text] [Related]  

  • 17. [Risk assessment in genetic techniques].
    Hobom G
    Verh Dtsch Ges Inn Med; 1990; 96():465-9. PubMed ID: 2092466
    [No Abstract]   [Full Text] [Related]  

  • 18. The regulation of biotechnology products as "toxics".
    Shanks PL; Gibbons SL
    Healthspan; 1985 Feb; 2(2):21-8. PubMed ID: 10289625
    [No Abstract]   [Full Text] [Related]  

  • 19. Testimony before the Subcommittee on Natural Resources, Agriculture Research and Environment, and the Subcommittee on Science, Research and Technology of the Committee on Science and Technology, June 23, 1986.
    Mellon MG
    Recomb DNA Tech Bull; 1986 Sep; 9(3):162-70. PubMed ID: 3466240
    [No Abstract]   [Full Text] [Related]  

  • 20. [Recombinant strains: their biological properties and the safety measures in working with them].
    Vorob'ev AA; Khoroshko NV; Selezneva OIu
    Vestn Ross Akad Med Nauk; 1993; (2):31-7. PubMed ID: 7688617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.